2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 578

Study of the Production of Antinuclear Antibodies and Anti-Ds DNA Antibodies in Rheumatoid Arthritis Patients Treated with TNF Inhibitors
Abstract Number: 1304

Studying MR-Detected Inflammation in Symptom-Free Persons from the General Population to Generate Ramris-Based Reference Values
Abstract Number: 1428

Subchondral Bone Structure and Pain Behaviors in Complete Freund’s Adjuvant (CFA) Monoarthritis in Mice Treated with Intra-Articular (IA) Neurotoxin
Abstract Number: 164

Subclinical Ankle Involvement in Rheumatoid Arthritis. a Multicentre Ultrasound Study
Abstract Number: 825

Subclinical Atherosclerosis and Estimation of Cardiovascular Risk in Systemic Sclerosis
Abstract Number: 1700

Subclinical Atherosclerosis in Ankylosing Spondylitis. Does It Really Exist and Which Are the Effects of Treatments? a Systematic Review
Abstract Number: 1709

Subclinical Atherosclerosis in Patients with Psoriatic Arthritis and the Role of Vitamin D
Abstract Number: 1890

Subclinical Biventricular Systolic Function Is Impaired in Patients with Systemic Sclerosis with Real Time 3-D Echpcardiography: 1 Year Follow-up Study
Abstract Number: 645

Subclinical Cardiovascular Involvement in Patients with Primary Sjögren Syndrome
Abstract Number: 2514

Subclinical Reduced Ovarian Reserve in Adult Polymiositis Patients
Abstract Number: 299

Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody
Abstract Number: 1409

Subglottic Stenosis: A Unique Inflammatory Disorder
Abstract Number: 1541

Subgroups of Established Rheumatoid Arthritis Patients Can be Characterized By Patient and Physician Assessment Discrepancy, Anxiety and Depression and Presence of Depression Might be Associated with Slower Response to Treatment
Abstract Number: 185

Success Rate and Utility of Ultrasound Guided Synovial Biopsies in Clinical Practice
Abstract Number: 1397

Successful Treatment of Cardiac Sarcoidosis with Biologic and Immunosuppressive Combination Therapy

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].